Pricing Log in Create free account

Skye Bioscience, Inc. (SKYE) vs Xenetic Biosciences, Inc. (XBIO)

Skye Bioscience, Inc. and Xenetic Biosciences, Inc. are both Biotechnology companies. Skye Bioscience, Inc. and Xenetic Biosciences, Inc. are of similar size ($4.6M and $4.4M). Skye Bioscience, Inc. has the higher net margin (0.00% vs −75.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Xenetic Biosciences, Inc. leads on 9 and Skye Bioscience, Inc. on 4.

Valuation

Metric SKYE XBIO Biotechnology median
P/E n/m n/m 10.60
P/S 16.46 1.32 9.40
P/B n/m 0.71 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.40 0.66
EV/Sales 3.61 (0.32) 9.02
Earnings yield (1,026.26%) (64.48%) (32.88%)
Free cash flow yield (779.11%) (53.86%) (23.13%)

Profitability

Metric SKYE XBIO Biotechnology median
Gross margin 68.04% 100.00% 68.51%
Operating margin 0.00% (81.01%) 0.00%
Net margin 0.00% (75.90%) 0.00%
Free cash flow margin 0.00% (70.93%) 0.00%
Return on equity (233.87%) (47.05%) (51.96%)
Return on assets (159.80%) (40.17%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SKYE XBIO Biotechnology median
Revenue growth (TTM) — 33.30% 6.76%
EPS growth (last fiscal year) (93.15%) 38.52% 29.88%
Revenue growth, 5-year CAGR — 46.78% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SKYE XBIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.95 7.43 4.97
Net debt to EBITDA 0.45 2.78 1.01

Dividend

Metric SKYE XBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SKYE XBIO Biotechnology median
Market cap 4.61m 4.37m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack